SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001628280-23-011646
Filing Date
2023-04-14
Accepted
2023-04-14 16:51:43
Documents
18
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 PRE 14A proxywithcard2023.htm PRE 14A 748679
2 board_recxpropsalfive.jpg GRAPHIC 117570
3 board_recxpropsalfour.jpg GRAPHIC 116906
4 chart-1bea92332cb64392a8b.jpg GRAPHIC 16694
5 chart-4f315dc2bc514fd0950.jpg GRAPHIC 106751
6 chart-63d28b36bbcb4a42a6e.jpg GRAPHIC 117740
7 chart-80574c606ec54364863.jpg GRAPHIC 15947
8 chart-866617c4a11940d891e.jpg GRAPHIC 13600
9 finalproxycard001.jpg GRAPHIC 161230
10 finalproxycard002.jpg GRAPHIC 140769
11 neoleukin_icon-01.jpg GRAPHIC 606581
12 neoleukin_icon-02.jpg GRAPHIC 587795
13 neoleukin_icon-03.jpg GRAPHIC 597543
14 neoleukin_icon-04.jpg GRAPHIC 578400
15 neoleukin_logo.jpg GRAPHIC 43055
16 recommendation-01.jpg GRAPHIC 53195
17 recommendation-02.jpg GRAPHIC 52869
18 recommendation-03.jpg GRAPHIC 52390
  Complete submission text file 0001628280-23-011646.txt   5385960
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36327 | Film No.: 23821816
SIC: 2834 Pharmaceutical Preparations